{
  "id": 4470587,
  "title": "South Africa Grapples With The Promise and Price of Injectable Lenacapavir to Prevent HIV",
  "url": "https://urgent.news/2026/08/30/south-africa-grapples-with-the-promise-and-price-of-injectable",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-30T17:37:33.000Z",
  "source": {
    "name": "Health Policy Watch",
    "slug": "health-policy-watch",
    "url": "https://healthpolicy-watch.news/south-africa-grapples-with-the-promise-and-price-of-injectable-prevention-drug-lenacapavir/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The antiretroviral medicine lenacapavir, delivered via injection every six months, is almost completely effective in preventing HIV. But it is expensive at present, and millions will need to be initiated on it every year to make a dent on HIV transmission in South Africa. CAPE TOWN – South Africa has the biggest population of people […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}